경남제약

경남제약 has filed trades across 2 companies (mainly through DART (FSS)), most often in 빌리언스 and 한주에이알티. We count 27 filings; the first trade dates from 10 January 2024 and the latest from 6 May 2026.

Both buying and selling appear: 23 purchases worth €181k, against 3 sales. The amount is not disclosed for 25 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 3 purchases and no sales on the market.

1 out of 13 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 6 May 2026, the filings show a transaction in 한주에이알티. The most recent open-market purchase was published on 6 March 2026, 226 days ago. The median gap between a trade and its publication by DART (FSS) is 3 days. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from DART (FSS). Past trades are no guide to future returns.